Evidence map›Paper›PMID 22495652›Full record

ArticleStatistics in medicine2012

Supervised Bayesian latent class models for high-dimensional data.

Stacia M Desantis, E Andrés Houseman, Brent A Coull, Catherine L Nutt, Rebecca A Betensky

Abstract read
In one paragraph

Article in Statistics in medicine, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Stacia M DesantisDivision of Biostatistics and Epidemiology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA. desantis@musc.edu
E Andrés Houseman
Brent A Coull
Catherine L Nutt
Rebecca A Betensky
Cancer Research And Biostatistics · USHarvard University · USJohn Brown University · USMedical University of South Carolina · US

Funding

THE ROLE OF ADVANCED CAA IN ALZHEIMER'S DEMENTIAP50AG005134 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI HYMAN, BRADLEY T. · 1985 to 2018
$42.1M
Statistical Methods for Analysis of Failure Time DataR01CA075971 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI BETENSKY, REBECCA A. · 2003 to 2009
$1.3M
Statistical Methods for Analysis of Quantitative LOHR03CA105956 · NCI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI BETENSKY, REBECCA A. · 2003 to 2004
$164k
Statistical Methods for Analysis of Array CGH DataR03CA121884 · NCI · HARVARD SCHOOL OF PUBLIC HEALTH · PI BETENSKY, REBECCA A. · 2006 to 2007
$162k
NCI NIH HHS R01 CA075971NCI NIH HHS R03 CA105956NCI NIH HHS R03 CA121884NIA NIH HHS P50 AG005134
6 · The paper itself

Abstract

High-grade gliomas are the most common primary brain tumors in adults and are typically diagnosed using histopathology. However, these diagnostic categories are highly heterogeneous and do not always correlate well with survival. In an attempt to refine these diagnoses, we make several immunohistochemical measurements of YKL-40, a gene previously shown to be differentially expressed between diagnostic groups. We propose two latent class models for classification and variable selection in the presence of high-dimensional binary data, fit by using Bayesian Markov chain Monte Carlo techniques. Penalization and model selection are incorporated in this setting via prior distributions on the unknown parameters. The methods provide valid parameter estimates under conditions in which standard supervised latent class models do not, and outperform two-stage approaches to variable selection and parameter estimation in a variety of settings. We study the properties of these methods in simulations, and apply these methodologies to the glioma study for which identifiable three-class parameter estimates cannot be obtained without penalization. With penalization, the resulting latent classes correlate well with clinical tumor grade and offer additional information on survival prognosis that is not captured by clinical diagnosis alone. The inclusion of YKL-40 features also increases the precision of survival estimates. Fitting models with and without YKL-40 highlights a subgroup of patients who have glioblastoma (GBM) diagnosis but appear to have better prognosis than the typical GBM patient.

Indexed as

Bayes TheoremModels, StatisticalAdipokinesAgedBrain NeoplasmsChitinase-3-Like Protein 1Computer SimulationGliomaHumansLectinsMarkov ChainsMonte Carlo MethodNeoplasm GradingSurvival AnalysisAdipokinesCHI3L1 protein, humanChitinase-3-Like Protein 1Lectins

Identifiers

PMID22495652
PMCPMC3701307
OpenAlexW2063404551

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.